Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
Merck
Dow
Chinese Patent Office
Healthtrust
Cerilliant
Daiichi Sankyo
US Army
Federal Trade Commission

Generated: January 18, 2018

DrugPatentWatch Database Preview

LACTULOSE - Generic Drug Details

« Back to Dashboard

What are the generic sources for lactulose and what is the scope of lactulose freedom to operate?

Lactulose
is the generic ingredient in fourteen branded drugs marketed by Cumberland Pharms, Sanofi Aventis Us, Alra, Actavis Mid Atlantic, Solvay, Teva Pharms, Ani Pharms, Apotex Inc, Fresenius Kabi, Hi Tech Pharma, Morton Grove, Paco, Pharm Assoc, Vintage Pharms, Vistapharm, West-ward Pharms Int, Nostrum Labs, Morton Grove Pharms, Bio-pharm Inc, and Roxane, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for lactulose. Twenty suppliers are listed for this compound.
Pharmacology for LACTULOSE
Medical Subject Heading (MeSH) Categories for LACTULOSE

US Patents and Regulatory Information for LACTULOSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay LACTULOSE lactulose SOLUTION;ORAL, RECTAL 017906-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms LACTULOSE lactulose SOLUTION;ORAL, RECTAL 090426-001 Nov 21, 2008 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Morton Grove GENERLAC lactulose SOLUTION;ORAL, RECTAL 071842-001 Sep 27, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Morton Grove Pharms GENERLAC lactulose SOLUTION;ORAL, RECTAL 074603-001 Oct 31, 1996 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Morton Grove LACTULOSE lactulose SOLUTION;ORAL 074602-001 Nov 14, 1996 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nostrum Labs LAXILOSE lactulose SOLUTION;ORAL 073686-001 May 28, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Paco LACTULOSE lactulose SOLUTION;ORAL 073160-001 Aug 25, 1992 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us CHRONULAC lactulose SOLUTION;ORAL 017884-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int LACTULOSE lactulose SOLUTION;ORAL 073591-001 May 29, 1992 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nostrum Labs ACILAC lactulose SOLUTION;ORAL, RECTAL 073685-001 May 28, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for LACTULOSE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us CEPHULAC lactulose SOLUTION;ORAL, RECTAL 017657-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us CEPHULAC lactulose SOLUTION;ORAL, RECTAL 017657-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us CEPHULAC lactulose SOLUTION;ORAL, RECTAL 017657-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us CEPHULAC lactulose SOLUTION;ORAL, RECTAL 017657-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us CEPHULAC lactulose SOLUTION;ORAL, RECTAL 017657-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us CEPHULAC lactulose SOLUTION;ORAL, RECTAL 017657-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Covington
Citi
Fuji
US Army
Argus Health
Merck
Federal Trade Commission
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot